Literatures

Primary Site >> Colorectal Cancer

Gene >> CD55

1.
Journal:	Br J Cancer. 1992 Nov;66(5):810-4.
Title:	Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
Author:	Koretz, K\|Bruderlein, S\|Henne, C\|Moller, P
PMID:	1384641

2.
Journal:	Gastroenterology. 1995 Sep;109(3):826-31.
Title:	Detection of decay-accelerating factor in stool specimens of patients with colorectal cancer.
Author:	Mizuno, M\|Nakagawa, M\|Uesu, T\|Inoue, H\|Inaba, T\|Ueki, T\|Nasu, J\|Okada, H\|Fujita, T\|Tsuji, T
PMID:	7544751

3.
Journal:	Am J Pathol. 1996 Jul;149(1):129-42.
Title:	Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Author:	Niehans, G A\|Cherwitz, D L\|Staley, N A\|Knapp, D J\|Dalmasso, A P
PMID:	8686736

4.
Journal:	APMIS. 1998 Sep;106(9):869-78.
Title:	The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
Author:	Thorsteinsson, L\|O'Dowd, G M\|Harrington, P M\|Johnson, P M
PMID:	9808413

5.
Journal:	Eur J Cancer. 1999 Jan;35(1):117-24.
Title:	Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Author:	Schmitt, C A\|Schwaeble, W\|Wittig, B M\|Meyer zum Buschenfelde, K H\|Dippold, W G
PMID:	10211099

6.
Journal:	Int J Cancer. 2000 Jan 1;85(1):87-92.
Title:	105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses.
Author:	Durrant, L G\|Buckley, D J\|Robins, R A\|Spendlove, I
PMID:	10585589

7.
Journal:	Clin Cancer Res. 2000 Feb;6(2):422-30.
Title:	A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55.
Author:	Durrant, L G\|Maxwell-Armstrong, C\|Buckley, D\|Amin, S\|Robins, R A\|Carmichael, J\|Scholefield, J H
PMID:	10690519

8.
Journal:	Eur J Immunol. 2000 Oct;30(10):2944-53.
Title:	A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
Author:	Spendlove, L\|Li, L\|Potter, V\|Christiansen, D\|Loveland, B E\|Durrant, L G
PMID:	11069077

9.
Journal:	Cancer Res. 2001 Jan 15;61(2):654-8.
Title:	Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer.
Author:	Chen, R\|Eshleman, J R\|Brodsky, R A\|Medof, M E
PMID:	11212264

10.
Journal:	J Gastrointest Surg. 2001 Nov-Dec;5(6):673-9.
Title:	Expression of 17-1A antigen and complement resistance factors CD55 and CD59 on liver metastasis in colorectal cancer.
Author:	Hosch, S B\|Scheunemann, P\|Luth, M\|Inndorf, S\|Stoecklein, N H\|Erbersdobler, A\|Rehders, A\|Gundlach, M\|Knoefel, W T\|Izbicki, J R
PMID:	12086907

11.
Journal:	Curr Opin Investig Drugs. 2001 Jul;2(7):959-66.
Title:	Immunization against tumor cell surface complement-regulatory proteins.
Author:	Durrant, L G\|Spendlove, I
PMID:	11757799

12.
Journal:	J Lab Clin Med. 2001 Sep;138(3):186-92.
Title:	Epidermal growth factor induces expression of decay-accelerating factor in human colonic cancer cells via the mitogen-activated protein kinase pathway.
Author:	Takeuchi, K\|Mizuno, M\|Uesu, T\|Nasu, J\|Kawada, M\|Hori, S\|Okada, H\|Endo, Y\|Fujita, T\|Tsuji, T
PMID:	11528371

13.
Journal:	Br J Cancer. 2001 Jun 1;84(11):1443-6.
Title:	Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer.
Author:	Maxwell-Armstrong, C A\|Durrant, L G\|Buckley, T J\|Scholefield, J H\|Robins, R A\|Fielding, K\|Monson, J R\|Guillou, P\|Calvert, H\|Carmichael, J\|Hardcastle, J D
PMID:	11384090

14.
Journal:	J Gastroenterol Hepatol. 2001 Feb;16(2):184-9.
Title:	Polymorphic expression of decay-accelerating factor in human colorectal cancer.
Author:	Nakagawa, M\|Mizuno, M\|Kawada, M\|Uesu, T\|Nasu, J\|Takeuchi, K\|Okada, H\|Endo, Y\|Fujita, T\|Tsuji, T
PMID:	11207899

15.
Journal:	Br J Cancer. 2001 Jan 5;84(1):80-6.
Title:	CD55 is over-expressed in the tumour environment.
Author:	Li, L\|Spendlove, I\|Morgan, J\|Durrant, L G
PMID:	11139317

16.
Journal:	Eur J Immunol. 2002 Jan;32(1):128-35.
Title:	Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
Author:	Gelderman, Kyra A\|Kuppen, Peter J K\|Bruin, Wouter\|Fleuren, Gert Jan\|Gorter, Arko
PMID:	11754353

17.
Journal:	J Immunoassay Immunochem. 2002;23(4):497-507.
Title:	Advances in the development of a reliable assay for the measurement of stool decay-accelerating factor in the detection of colorectal cancer.
Author:	Iwagaki, Naofumi\|Mizuno, Motowo\|Nasu, Jyunichirou\|Mizuno, Masakatsu\|Okazaki, Hiroaki\|Hori, Shinichirou\|Yamamoto, Kazuhide\|Okada, Hiroyuki\|Tsuji, Takao\|Fujita, Teizo\|Shiratori, Yasushi
PMID:	12458732

18.
Journal:	J Lab Clin Med. 2003 Nov;142(5):306-12.
Title:	Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor.
Author:	Kawada, Mikihiro\|Mizuno, Motowo\|Nasu, Junichirou\|Uesu, Tokurou\|Okazaki, Hiroaki\|Okada, Hiroyuki\|Shimomura, Hiroyuki\|Yamamoto, Kazuhide\|Tsuji, Takao\|Fujita, Teizo\|Shiratori, Yasushi
PMID:	14647034

19.
Journal:	Am J Gastroenterol. 2003 Nov;98(11):2550-5.
Title:	Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
Author:	Mizuno, Masakatsu\|Mizuno, Motowo\|Iwagaki, Naofumi\|Nasu, Junichirou\|Okazaki, Hiroaki\|Yamamoto, Kazuhide\|Okada, Hiroyuki\|Tsuji, Takao\|Fujita, Teizo\|Shiratori, Yasushi
PMID:	14638362

20.
Journal:	Cancer Immunol Immunother. 2003 Oct;52(10):638-42. Epub 2003 Jun 14.
Title:	Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.
Author:	Durrant, L G\|Chapman, M A\|Buckley, D J\|Spendlove, I\|Robins, R A\|Armitage, N C
PMID:	12811528

21.
Journal:	J Lab Clin Med. 2004 Mar;143(3):169-74.
Title:	Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.
Author:	Okazaki, Hiroaki\|Mizuno, Motowo\|Nasu, Junichirou\|Makidono, Chiho\|Hiraoka, Sakiko\|Yamamoto, Kazuhide\|Okada, Hiroyuki\|Fujita, Teizo\|Tsuji, Takao\|Shiratori, Yasushi
PMID:	15007307

22.
Journal:	Clin Cancer Res. 2004 Apr 15;10(8):2797-803.
Title:	Loss of CD55 is associated with aggressive breast tumors.
Author:	Madjd, Zahra\|Durrant, Lindy G\|Bradley, Richard\|Spendlove, Ian\|Ellis, Ian O\|Pinder, Sarah E
PMID:	15102687

23.
Journal:	J Biol Chem. 2005 Jan 7;280(1):476-83. Epub 2004 Nov 1.
Title:	Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer.
Author:	Holla, Vijaykumar R\|Wang, Dingzhi\|Brown, Joanne R\|Mann, Jason R\|Katkuri, Sharada\|DuBois, Raymond N
PMID:	15520008

24.
Journal:	Exp Mol Pathol. 2006 Aug;81(1):77-84. Epub 2005 Dec 27.
Title:	Dexamethasone modifies the susceptibility to serum cytotoxicity and increases the metastatic efficiency of a colon carcinoma cell line.
Author:	Yoshida, Yukio\|Kishimoto, Takashi\|Ishiguro, Hiroshi\|Nagai, Yuichiro\|Koda, Keiji\|Takiguchi, Nobuhiro\|Miyazaki, Masaru\|Ishikura, Hiroshi
PMID:	16380115

25.
Journal:	Proteomics. 2006 Mar;6(6):1791-802.
Title:	Multiplex detection of surface molecules on colorectal cancers.
Author:	Ellmark, Peter\|Belov, Larissa\|Huang, Pauline\|Lee, C Soon\|Solomon, Michael J\|Morgan, Daniel K\|Christopherson, Richard I
PMID:	16485257

26.
Journal:	Eur J Immunol. 2006 Apr;36(4):977-84.
Title:	Cross-linking tumor cells with effector cells via CD55 with a bispecific mAb induces beta-glucan-dependent CR3-dependent cellular cytotoxicity.
Author:	Gelderman, Kyra A\|Lam, Suzanne\|Sier, Cornelis F\|Gorter, Arko
PMID:	16525993

27.
Journal:	Neoplasia. 2006 Jan;8(1):69-78.
Title:	Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo.
Author:	Loberg, Robert D\|Day, LaShon L\|Dunn, Rodney\|Kalikin, Linda M\|Pienta, Kenneth J
PMID:	16533428

28.
Journal:	Clin Cancer Res. 2006 Dec 15;12(24):7389-96. Epub 2006 Nov 22.
Title:	A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
Author:	Ullenhag, Gustav J\|Spendlove, Ian\|Watson, Nicholas F S\|Indar, Adrian A\|Dube, Mukul\|Robins, Richard A\|Maxwell-Armstrong, Charles\|Scholefield, John H\|Durrant, Lindy G
PMID:	17121873

29.
Journal:	Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Feb;103(2):231-9. Epub
Title:	Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Author:	Ravindranath, Naren M H\|Shuler, Charles
PMID:	17234541

30.
Journal:	J Proteome Res. 2011 Jul 1;10(7):3040-9.
Title:	High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers.
Author:	Wisniewski, Jacek R\|Ostasiewicz, Pawel\|Mann, Matthias
PMID:	21526778

31.
Journal:	Tissue Antigens. 2013 Jul;82(1):26-34.
Title:	Characterization of novel CD55 isoforms expression in normal and neoplastic tissues.
Author:	Vainer, E D\|Meir, K\|Furman, M\|Semenenko, I\|Konikoff, F\|Vainer, G W
PMID:	23692281

32.
Journal:	Arch Biochem Biophys. 2014 Jan 1;541:21-9.
Title:	A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.
Author:	Oyama, Satomi\|Fujino, Hiromichi\|Yamazaki, Risa\|Okura, Iori\|Regan, John W\|Awata, Atsuko\|Arai, Takayoshi\|Murayama, Toshihiko
PMID:	24239863

33.
Journal:	Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15;306(12):G1056-64.
Title:	CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of alpha-gal xenoantigen in colon tumor cells.
Author:	Wu, Yanxia\|Wang, Yaogeng\|Qin, Feng\|Wang, Zhu\|Wang, Yu\|Yang, Yajun\|Zheng, Hong\|Wang, Yanping
PMID:	24763553

34.
Journal:	Arch Pathol Lab Med. 2014 Jul;138(7):910-9.
Title:	Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer.
Author:	Shang, Yulong\|Chai, Na\|Gu, Yong\|Ding, Li\|Yang, Yan\|Zhou, Jinfeng\|Ren, Gui\|Hao, Xiaoke\|Fan, Daiming\|Wu, Kaichun\|Nie, Yongzhan
PMID:	24978917

35.
Journal:	J Infect Chemother. 2015 Jan;21(1):8-15.
Title:	Silencing of CD59 enhanced the sensitivity of HT29 cells to 5-Fluorouracil and Oxaliplatin.
Author:	Yin, Haipeng\|Li, Cuiling\|Wang, Shaoyu\|Guo, Qiang\|Ren, Xia\|Jiang, Guosheng
PMID:	25444672

36.
Journal:	J Extracell Vesicles. 2016 Apr 15;5:25355.
Title:	Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples.
Author:	Belov, Larissa\|Matic, Kieran J\|Hallal, Susannah\|Best, O Giles\|Mulligan, Stephen P\|Christopherson, Richard I
PMID:	27086589

37.
Journal:	Mol Med Rep. 2017 Dec;16(6):9375-9382.
Title:	Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model.
Author:	Xiao, Boduan\|Qin, Yun\|Ying, Chang\|Ma, Buyun\|Wang, Binrong\|Long, Fei\|Wang, Ruwei\|Fang, Ling\|Wang, Yigang
PMID:	29039580